Ryan D. Maynard, EVP & CFO at RIGEL PHARMACEUTICALS INC (RIGL), sold 51,698 shares at $10.55 ($545K) on 2012-09-07, disclosed to the SEC on 2012-09-11.
Open-market sale of $545k RIGL by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.55 | 34,112 | $360K | 66.0% |
| 2 | $10.52 | 17,586 | $185K | 34.0% |
| Total | $10.54 avg | 51,698 | $545K | 100% |
| Filing → |
| IOVA | BUY | 2022-06-02 | $51K | — | Filing → |
| RIGL | SELL | 2017-11-07 | $390K | — | Filing → |
| RIGL | SELL | 2012-09-14 | $249K | — | Filing → |